Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England journal of medicine 371 (11), 1005-1015, 2014 | 1493 | 2014 |
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology I Qaddoumi, W Orisme, J Wen, T Santiago, K Gupta, JD Dalton, B Tang, ... Acta neuropathologica 131, 833-845, 2016 | 365 | 2016 |
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia J Zhang, K McCastlain, H Yoshihara, B Xu, Y Chang, ML Churchman, ... Nature genetics 48 (12), 1481-1489, 2016 | 295 | 2016 |
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136, 211-226, 2018 | 234 | 2018 |
Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ... Cancer discovery 10 (7), 942-963, 2020 | 213 | 2020 |
Genomic subtyping and therapeutic targeting of acute erythroleukemia I Iacobucci, J Wen, M Meggendorfer, JK Choi, L Shi, SB Pounds, ... Nature genetics 51 (4), 694-704, 2019 | 125 | 2019 |
Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia E Waanders, Z Gu, SM Dobson, Ž Antić, JC Crawford, X Ma, ... Blood cancer discovery 1 (1), 96-111, 2020 | 122 | 2020 |
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome YH Park, S Lal, JE Lee, YL Choi, J Wen, S Ram, Y Ding, SH Lee, E Powell, ... Nature communications 11 (1), 6175, 2020 | 115 | 2020 |
Applications of single-cell RNA sequencing in drug discovery and development B Van de Sande, JS Lee, E Mutasa-Gottgens, B Naughton, W Bacon, ... Nature Reviews Drug Discovery 22 (6), 496-520, 2023 | 94 | 2023 |
Baseline frequency of inflammatory Cxcl9-expressing tumor-associated macrophages predicts response to avelumab treatment Y Qu, J Wen, G Thomas, W Yang, W Prior, W He, P Sundar, X Wang, ... Cell reports 32 (1), 2020 | 73 | 2020 |
Structure and evolution of double minutes in diagnosis and relapse brain tumors K Xu, L Ding, TC Chang, Y Shao, J Chiang, H Mulder, S Wang, TI Shaw, ... Acta neuropathologica 137, 123-137, 2019 | 72 | 2019 |
Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis JCH Chiang, JH Harreld, R Tanaka, X Li, J Wen, C Zhang, DR Boué, ... Neuro-oncology 21 (6), 800-808, 2019 | 57 | 2019 |
A comprehensive collection of systems biology data characterizing the host response to viral infection BD Aevermann, BE Pickett, S Kumar, EB Klem, S Agnihothram, ... Scientific data 1 (1), 1-21, 2014 | 45 | 2014 |
Custom gene capture and next-generation sequencing to resolve discordant ALK status by FISH and IHC in lung adenocarcinoma JS Jang, X Wang, PT Vedell, J Wen, J Zhang, DW Ellison, JM Evans, ... Journal of Thoracic Oncology 11 (11), 1891-1900, 2016 | 42 | 2016 |
St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia J Zhang, K McCastlain, H Yoshihara, B Xu, Y Chang, ML Churchman, ... Nat Genet 48 (12), 1481-1489, 2016 | 42 | 2016 |
Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas K Fukuoka, Y Mamatjan, R Tatevossian, M Zapotocky, S Ryall, ... Neuro-oncology 22 (10), 1474-1483, 2020 | 37 | 2020 |
MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children’s Oncology Group Study K Matlawska-Wasowska, H Kang, M Devidas, J Wen, RC Harvey, ... Leukemia 30 (9), 1909-1912, 2016 | 36 | 2016 |
Genome-wide analysis of alternative transcripts in human breast cancer J Wen, KH Toomer, Z Chen, X Cai Breast cancer research and treatment 151, 295-307, 2015 | 36 | 2015 |
Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov; 2020 M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ... CD-19-1030.[Europe PMC free article][Abstract][CrossRef][Google Scholar] 10 …, 2020 | 35 | 2020 |
T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model HP Llewellyn, S Arat, J Gao, J Wen, S Xia, D Kalabat, E Oziolor, ... Journal of hepatology 75 (5), 1083-1095, 2021 | 23 | 2021 |